Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.110
-0.040 (-3.48%)
At close: Mar 28, 2025, 4:00 PM
1.090
-0.020 (-1.79%)
After-hours: Mar 28, 2025, 7:33 PM EDT
Vivani Medical Employees
Vivani Medical had 44 employees as of December 31, 2023. The number of employees decreased by 6 or -12.00% compared to the previous year.
Employees
44
Change (1Y)
-6
Growth (1Y)
-12.00%
Revenue / Employee
n/a
Profits / Employee
-$533,227
Market Cap
65.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 44 | -6 | -12.00% |
| Dec 31, 2022 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VANI News
- 3 days ago - Vivani Medical Announces $8.25M Private Placement Equity Financing - GlobeNewsWire
- 4 days ago - Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing - GlobeNewsWire
- 6 days ago - Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025 - Business Wire
- 17 days ago - Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults - Business Wire
- 18 days ago - Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business - Business Wire
- 18 days ago - EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value - Benzinga
- 3 months ago - Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia - Business Wire
- 4 months ago - Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Business Wire